Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pediatr Blood Cancer. 2011 Feb;56(2):304-6. doi: 10.1002/pbc.22842.
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare autosomal recessive disorder characterized by thrombocytopenia from failure of megakaryopoiesis. CAMT is one of the bone marrow failure syndromes, and the disease progression may involve other lineages leading to pancytopenia. The genetic background of CAMT is mutations in the MPL gene encoding the thrombopoietin receptor. Here, we describe a Korean male with CAMT. Molecular genetic analyses by direct sequencing revealed that he was compound heterozygous for two nonsense mutations in MPL, Tyr63X (c.189C>A), and Arg357X (c.1069C>T), the latter being a novel mutation.
先天性巨核细胞血小板减少症(CAMT)是一种罕见的常染色体隐性疾病,其特征是巨核细胞生成失败导致血小板减少。CAMT 是骨髓衰竭综合征之一,疾病进展可能涉及其他谱系,导致全血细胞减少。CAMT 的遗传背景是编码血小板生成素受体的 MPL 基因的突变。在这里,我们描述了一名患有 CAMT 的韩国男性。直接测序的分子遗传学分析显示,他是 MPL 中两个无意义突变的复合杂合子,即 Tyr63X(c.189C>A)和 Arg357X(c.1069C>T),后者是一种新的突变。